BioSpace News Archive

Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenix’s electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™ for another year.

Today Inversago Pharma Inc., a preclinical-stage biotech company developing new CB1 blockers for the treatment of targeted metabolic disorders, announced the appointment of Dr. Caroline Fradette as Vice-President, Clinical Research.

BioTalent Canada marked this year’s Global Biotech Week with the announcement of the release of their fifth annual National Compensation Guide for Canada’s bio-economy.

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced that it has applied the CE mark to the PGDx elio™ tissue complete assay.

Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company developing first-in-class Superkines and Empowered Cytokines, today presented updated clinical results from its Phase 2b clinical trial of MDNA55,

The Johnson & Johnson Medical Devices Companies* today announced that DePuy Synthes has launched the CONDUIT Interbody Platform with EIT Cellular Titanium Technology, further expanding its comprehensive offering to treat degenerative spine disease.

CVS Health announced that MinuteClinic, the company’s retail medical clinic, joins a premier group of organizations that have received Pathway to Excellence® designation from the American Nurses Credentialing Center.

The article is published in Frontiers in Immunology and entitled “Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury,”

VTA Calls On Regulators And Lawmakers To Come Together With The Industry To Implement Meaningful And Critical Alternatives That Address Youth Issues Without Destroying $24.5 Billion In Total Vapor Industry Positive Economic Impact

Camfil USA, a leader in air filtration, announces exciting news for cleanroom facility engineers and all stakeholders. Their new Megalam EnerGuard offers significantly less than a 1% efficiency performance failure with lower cost compared to glass fiber and competitive filters, a longer service life, energy cost savings, operational efficiencies and manufacturing process integrity.